NCT01764061已完成不适用
Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Hemolysis level at 42 days of storage
研究概览
简要总结
The purpose of this study is to validate that single units of RBCs collected by the Haemonetics MCS®+ 8150 system using LN832 disposable sets during an interrupted double red cell collection protocol meet all in vitro FDA requirements for non-leukoreduced red blood cells, and to provide data to support the 510(k) clearance of the MCS®+ 8150 system using LN832 disposable sets for this intended use.
详细描述
This study will take place at two sites (Blood Center of Wisconsin (BCW) Milwaukee, WI and American Red Cross-Norfolk, VA).
- A standard double red cell collection protocol will be initiated using the Haemonetics MCS®+ 8150 system using LN832 disposable sets. The collection procedure will be terminated after collection of one RBC unit. The maximum target red cell volume will be selected based on the donor predonation weight as specified in the nomogram included in the MCS®+ 8150 operation manual.
- The RBC units will be stored for 42 days at 1° to 6°C.
- Upon collection and at 42 days after collection, the RBC units will be weighed and tested for hematology parameters (white blood cell count, red blood cell count, residual white blood cell count, hemoglobin, hematocrit, platelet count, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, red blood cell distribution width, and supernatant hemoglobin) and chemistry parameters (pH, potassium, glucose, lactate, and ATP).
- Acceptance criteria for this study are as follows:
- Hemolysis of less than or equal to 1% at 42 days of storage
- Maximum absolute red cell volume is less than or equal to the programmed absolute RBC target volume + 15%
- Minimum absolute red cell volume is greater than or equal to the programmed absolute RBC target volume - 15%
- After collection of sixty (60) evaluable RBC units, the study will be considered supportive of the intended use noted above if zero (0) units fail the acceptance criteria.
- If one (1) unit fails acceptance criteria after collection of sixty (60) evaluable RBC units, an additional seventy one (71) units will be collected.
- The study will be considered supportive of the intended use noted above if not more than one (1) total unit out of 131 evaluable units fails the acceptance criteria.
- If a total of two (2) units fail acceptance criteria, the study will not be considered supportive of the intended use noted above.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Males and Females ≥ 18 years of age
- •Males ≥ 130 pounds, Females ≥ 150 pounds
- •Males ≥ 5 feet, 1 inch, Females ≥ 5 feet, 3 inches
- •Hemoglobin ≥ 13.3 g/dL
- •Hematocrit ≥ 40%
- •Donor Eligibility: Meets all criteria as per sites' Research Blood Donation Record, Prior donation date (i.e. not less than 112 days for most recent double RBC unit donation, 56 days for most recent single RBC unit donation)
- •Subject must provide informed consent using an IRB informed consent form prior to undergoing any study related procedures.
排除标准
- •will be not fulfilling any of the inclusion criteria.
结局指标
主要结局
Hemolysis level at 42 days of storage
时间窗: 42 days
Absolute red cell volume
时间窗: 42 days
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
撤回
1 期
POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC UnitsAnemiaTransfusion ReactionNCT03056378New York Blood Center
已完成
1 期
A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and PharmacodynamicsNarcolepsy, Excessive Daytime SleepinessNCT02215499Concert Pharmaceuticals28
No Longer Available
不适用
A Single Patient Will be Treated With Individual Patient TCR-Transduced PBLNCT04194190National Institutes of Health Clinical Center (CC)
已完成
1 期
URMC Related Haplo-identical Donor BMTHematological DiseaseImmune DeficienciesSolid TumorsMultiple MyelomaLymphomaMyelofibrosisNCT02660281University of Rochester74
尚未招募
不适用
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related HemocytopeniaRefractory Immune Effector Cell-related HemocytopeniaNCT06729320Beijing GoBroad Hospital40
